Cases, number (%) | Controls, number (%) | |
---|---|---|
(n=88 612) | (n=886 120) | |
Partner bereavement | ||
Yes | 17 478 (19.72) | 168 940 (19.07) |
No | 71 134 (80.28) | 717 180 (80.93) |
Sex | ||
Female | 41 764 (47.13) | 417 649 (47.13) |
Male | 46 848 (52.87) | 468 480 (52.87) |
Age (years) | ||
18–49 | 6678 (7.54) | 66 780 (7.54) |
50–59 | 11 299 (12.75) | 112 990 (12.75) |
60–69 | 20 875 (23.56) | 208 750 (23.56) |
70–79 | 25 808 (29.12) | 258 080 (29.12) |
80–100 | 23 952 (27.03) | 239 520 (27.03) |
Civil status | ||
Cohabitant* | 47 956 (54.12) | 472 338 (53.30) |
Not cohabitant | 40 656 (45.88) | 413 782 (46.70) |
Education (years) | ||
<10 | 32 834 (37.05) | 313 635 (35.39) |
10–15 | 28 334 (31.98) | 280 719 (31.68) |
>15 | 10 278 (11.60) | 103 633 (11.70) |
Calendar time | ||
1995–2004 | 39 104 (44.13) | 391 040 (44.13) |
2004–2014 | 49 508 (55.87) | 495 080 (55.87) |
Previous hospital diagnoses | ||
Cardiovascular diseases | 29 895 (33.73) | 180 802 (20.40) |
Hypertension | 17 406 (19.64) | 108 813 (12.28) |
Ischaemic heart disease† | 16 680 (18.82) | 95 540 (10.78) |
Cardiomyopathy | 909 (1.03) | 2115 (0.24) |
Congestive heart failure | 6445 (7.27) | 26 414 (2,98) |
Hyperthyroidism | 1787 (2.02) | 11 527 (1.30) |
Diabetes mellitus | 11 009 (12.42) | 87 646 (9.89) |
Medicine‡ | ||
ACE or A2R inhibitors | 21 514 (24.28) | 151 337 (17.08) |
β-blockers | 19 176 (21.64) | 90 784 (10.25) |
Digoxin | 8071 (9.11) | 16 350 (1.85) |
Calcium channel blockers | 4583 (5.17) | 18 930 (2.14) |
Diuretics | 28 414 (32.07) | 181 005 (20.43) |
Nitrates | 6415 (7.24) | 29 455 (3.32) |
Thrombocyte function inhibitors | 23 441 (26.45) | 158 623 (17.90) |
Lipid modifying agents | 12 718 (14.35) | 102 710 (11.59) |
Vitamin K antagonists | 7744 (8.74) | 7801 (0.88) |
*Married or living with a cohabitant partner.
†Angina pectoris, acute myocardial infarction, chronic ischaemic heart disease.
‡Redeemed prescriptions 3 months before index date.
A2R, adenosine receptor.